Skip to content

GlycA, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)596-609
Number of pages14
JournalJournal of Internal Medicine
Issue number5
Early online date1 Jul 2019
DateAccepted/In press - 18 Jun 2019
DateE-pub ahead of print - 1 Jul 2019
DatePublished (current) - 1 Nov 2019


Background: Chronic diseases are associated with an inflammatory response. We determined the association of two inflammatory markers, GlycA and high-sensitivity C-reactive protein (hsCRP), with overall and cause-specific mortality in a cohort of men and women. Methods: Cox regression analyses were used to examine associations of GlycA and hsCRP with all-cause, cancer and cardiovascular mortality in 5526 subjects (PREVEND cohort; average follow-up 12.6 years). Results: GlycA was associated with all-cause mortality (n = 838), independent of clinical risk factors and hsCRP (hazard ratio 1.43 [95% confidence interval (CI): 1.09–1.87] for top versus bottom quartiles). For hsCRP, the association with all-cause mortality was nonsignificant after adjustment for GlycA. GlycA and hsCRP were associated with cancer mortality in men (n = 248), but not in women (n = 132). Neither GlycA nor hsCRP was independently associated with cardiovascular mortality (n = 201). In a meta-analysis of seven population-based studies, including 8153 deaths, the pooled multivariable-adjusted relative risk of GlycA for all-cause mortality was 1.74 (95% CI: 1.40–2.17) for top versus bottom quartiles. The association of GlycA with all-cause mortality was somewhat stronger than that of hsCRP. GlycA and hsCRP were not independently associated with cardiovascular mortality. The associations of GlycA and hsCRP with cancer mortality were present in men, but not in women. Conclusions: GlycA is significantly associated with all-cause mortality. GlycA and hsCRP were each not independently associated with cardiovascular mortality. The association of GlycA and hsCRP with cancer mortality appears to be driven by men.

    Research areas

  • C-reactive protein, GlycA, glycoproteins, inflammation, mortality, nuclear magnetic resonance spectroscopyPA

Download statistics

No data available



  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via Wiley at Please refer to any applicable terms of use of the publisher.

    Final published version, 1013 KB, PDF document

    Licence: CC BY-NC

  • Supplementary information PDF

    Final published version, 303 KB, PDF document

    Licence: CC BY-NC


View research connections

Related faculties, schools or groups